Read More 5 minute read Pharma Industry News Equillium secures financing to launch EQ504 Phase 1 trial in 2026 Equillium secures up to $50M to fund clinical entry of EQ504 mid-2026—discover how this financing shapes its immunology strategy. byPallavi MadhirajuAugust 11, 2025